Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury

Spinal cord injury (SCI) is a major cause of paralysis with no current therapies. Following SCI, large amounts of ATP and other nucleotides are released by the traumatized tissue leading to the activation of purinergic receptors that, in coordination with growth factors, induce lesion remodeling and...

Full description

Bibliographic Details
Main Authors: Rosa Gómez-Villafuertes Ph.D., Francisco Javier Rodríguez-Jiménez, Ana Alastrue-Agudo, Miodrag Stojkovic, María Teresa Miras-Portugal, Victoria Moreno-Manzano
Format: Article
Language:English
Published: SAGE Publishing 2015-08-01
Series:Cell Transplantation
Online Access:https://doi.org/10.3727/096368914X682828
_version_ 1818497756072771584
author Rosa Gómez-Villafuertes Ph.D.
Francisco Javier Rodríguez-Jiménez
Ana Alastrue-Agudo
Miodrag Stojkovic
María Teresa Miras-Portugal
Victoria Moreno-Manzano
author_facet Rosa Gómez-Villafuertes Ph.D.
Francisco Javier Rodríguez-Jiménez
Ana Alastrue-Agudo
Miodrag Stojkovic
María Teresa Miras-Portugal
Victoria Moreno-Manzano
author_sort Rosa Gómez-Villafuertes Ph.D.
collection DOAJ
description Spinal cord injury (SCI) is a major cause of paralysis with no current therapies. Following SCI, large amounts of ATP and other nucleotides are released by the traumatized tissue leading to the activation of purinergic receptors that, in coordination with growth factors, induce lesion remodeling and repair. We found that adult mammalian ependymal spinal cord-derived stem/progenitor cells (epSPCs) are capable of responding to ATP and other nucleotidic compounds, mainly through the activation of the ionotropic P2X 4 , P2X 7 , and the metabotropic P2Y 1 and P2Y 4 purinergic receptors. A comparative study between epSPCs from healthy rats versus epSPCis, obtained after SCI, shows a downregulation of P2Y 1 receptor together with an upregulation of P2Y 4 receptor in epSPCis. Moreover, spinal cord after severe traumatic contusion shows early and persistent increases in the expression of P2X 4 and P2X 7 receptors around the injury, which are completely reversed when epSPCis were ectopically transplanted. Since epSPCi transplantation significantly rescues neurological function after SCI in parallel to inhibition of the induced P2 ionotropic receptors, a potential avenue is open for therapeutic alternatives in SCI treatments based on purinergic receptors and the endogenous reparative modulation.
first_indexed 2024-12-10T18:49:18Z
format Article
id doaj.art-75af12911a594330860769dba14b616f
institution Directory Open Access Journal
issn 0963-6897
1555-3892
language English
last_indexed 2024-12-10T18:49:18Z
publishDate 2015-08-01
publisher SAGE Publishing
record_format Article
series Cell Transplantation
spelling doaj.art-75af12911a594330860769dba14b616f2022-12-22T01:37:22ZengSAGE PublishingCell Transplantation0963-68971555-38922015-08-012410.3727/096368914X682828Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord InjuryRosa Gómez-Villafuertes Ph.D.0Francisco Javier Rodríguez-Jiménez1Ana Alastrue-Agudo2Miodrag Stojkovic3María Teresa Miras-Portugal4Victoria Moreno-Manzano5Departamento de Bioquímica, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, SpainNeuronal and Tissue Regeneration Lab., Centro de Investigación Príncipe Felipe, Valencia, SpainNeuronal and Tissue Regeneration Lab., Centro de Investigación Príncipe Felipe, Valencia, SpainHuman Genetics, Faculty of Medical Sciences, University of Kragujevac, SerbiaDepartamento de Bioquímica, Facultad de Veterinaria, Universidad Complutense de Madrid, Madrid, SpainNeuronal and Tissue Regeneration Lab., Centro de Investigación Príncipe Felipe, Valencia, SpainSpinal cord injury (SCI) is a major cause of paralysis with no current therapies. Following SCI, large amounts of ATP and other nucleotides are released by the traumatized tissue leading to the activation of purinergic receptors that, in coordination with growth factors, induce lesion remodeling and repair. We found that adult mammalian ependymal spinal cord-derived stem/progenitor cells (epSPCs) are capable of responding to ATP and other nucleotidic compounds, mainly through the activation of the ionotropic P2X 4 , P2X 7 , and the metabotropic P2Y 1 and P2Y 4 purinergic receptors. A comparative study between epSPCs from healthy rats versus epSPCis, obtained after SCI, shows a downregulation of P2Y 1 receptor together with an upregulation of P2Y 4 receptor in epSPCis. Moreover, spinal cord after severe traumatic contusion shows early and persistent increases in the expression of P2X 4 and P2X 7 receptors around the injury, which are completely reversed when epSPCis were ectopically transplanted. Since epSPCi transplantation significantly rescues neurological function after SCI in parallel to inhibition of the induced P2 ionotropic receptors, a potential avenue is open for therapeutic alternatives in SCI treatments based on purinergic receptors and the endogenous reparative modulation.https://doi.org/10.3727/096368914X682828
spellingShingle Rosa Gómez-Villafuertes Ph.D.
Francisco Javier Rodríguez-Jiménez
Ana Alastrue-Agudo
Miodrag Stojkovic
María Teresa Miras-Portugal
Victoria Moreno-Manzano
Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury
Cell Transplantation
title Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury
title_full Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury
title_fullStr Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury
title_full_unstemmed Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury
title_short Purinergic Receptors in Spinal Cord-Derived Ependymal Stem/Progenitor Cells and Their Potential Role in Cell-Based Therapy for Spinal Cord Injury
title_sort purinergic receptors in spinal cord derived ependymal stem progenitor cells and their potential role in cell based therapy for spinal cord injury
url https://doi.org/10.3727/096368914X682828
work_keys_str_mv AT rosagomezvillafuertesphd purinergicreceptorsinspinalcordderivedependymalstemprogenitorcellsandtheirpotentialroleincellbasedtherapyforspinalcordinjury
AT franciscojavierrodriguezjimenez purinergicreceptorsinspinalcordderivedependymalstemprogenitorcellsandtheirpotentialroleincellbasedtherapyforspinalcordinjury
AT anaalastrueagudo purinergicreceptorsinspinalcordderivedependymalstemprogenitorcellsandtheirpotentialroleincellbasedtherapyforspinalcordinjury
AT miodragstojkovic purinergicreceptorsinspinalcordderivedependymalstemprogenitorcellsandtheirpotentialroleincellbasedtherapyforspinalcordinjury
AT mariateresamirasportugal purinergicreceptorsinspinalcordderivedependymalstemprogenitorcellsandtheirpotentialroleincellbasedtherapyforspinalcordinjury
AT victoriamorenomanzano purinergicreceptorsinspinalcordderivedependymalstemprogenitorcellsandtheirpotentialroleincellbasedtherapyforspinalcordinjury